Program overview
Context
Indication: Relapsed or Refractory Peripheral T-Cell Lymphoma
Mechanism: Unknown
Modality: Unknown
Sponsor: Kura Oncology, .
Results Not Found Signal
Tipifarnib
Tipifarnib is flagged as results not found signal because public records show public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 1/5
Recruitment burden: 1/5
Results availability: 3/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02464228 | https://clinicaltrials.gov/study/NCT00027872
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02464228 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | strict_eligibility_signal |
| NCT00027872 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | few_sites_large_trial_signal |